NCOA3 and Familial prostate cancer: It performs its antitumor functions by regulating oncogenic proteins such as EGFR, a steroid receptor coactivator 3 (SRC3), and androgen receptors in pancreatic, breast, and prostate cancers (106, 118, 119).